Method for producing blue-ear disease vaccine by culturing sensitive cell
A technology for sensitive cells and PRRS, applied in biochemical equipment and methods, tissue culture, microorganisms, etc., can solve problems such as low degree of automation, large product batch differences, and unstable quality of cells and PRRS vaccines.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Embodiment 1, microcarrier culture Marc145 cell production PRRS vaccine in 50 liters of bioreactors
[0027] Microcarrier: cytodex-1 (GE Life Sciences, Cat No.17-0485-03)
[0028] Porcine reproductive and respiratory syndrome virus: NVDC-JXA1 strain.
[0029] Medium: Marc145 cell reactor high-density medium (Beijing Qingda Tianyi Biotechnology Co., Ltd., Cat No.MD900, Lot No.080310)
[0030] In a 50-liter bioreactor, cytodex-1 was rinsed with PBS, soaked several times, and after autoclaving, Marc145 cells were inoculated into the bioreactor, and the cells grew to 2×10 6 After the cell density of cells / ml, perfusion culture was carried out until the viable cell density reached 6×10 6 After the cells / ml, the virus solution was replaced, and the porcine reproductive and respiratory syndrome virus was inoculated according to the virus multiplicity of infection MOI=0.015. Then, maintain the nutritional conditions required for virus propagation and the pH value of 6.9-7.3 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com